SitemapImprintDatenschutzerklärungdeutschenglish
MHH Logo

Combatting Bacterial Resistance in Europe (COMBACTE)

 

 

COMBACTE

Combatting Bacterial Resistance in Europe

 

 

Antimicrobial resistance (AMR) is a growing problem worldwide, and with few new drugs making it to the market, there is an urgent need for new medicines to treat resistant infections. Enter the IMI-funded COMBACTE project, which aims to give antibiotic drug development a much-needed boost by pioneering new ways of designing and implementing efficient clinical trials for novel antibiotics. COMBACTE forms part of the New Drugs for Bad Bugs (ND4BB) initiative, IMI’s wider programme to tackle AMR.

Link:

http://www.combacte.com/